Trial intelligence / Profile preview

Simvastatin added to platelet-rich fibrin for healing around immediate dental implants

PACTR202610603571975Completed

Sponsor
Suez Canal University
Start
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of simvastatin in edentulism and Oral surgical wound healing (2 arms), sponsored by Suez Canal University. Primary endpoint: Implant Stability Quotient. Started Dec 2023; status: completed.

02

Drugs

simvastatin
03

Conditions

edentulismOral surgical wound healing

Beyond the preview

Go deeper on PACTR202610603571975.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202610603571975.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call